1 active not recruiting. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Active not recruiting 1 |
Follow Common Variable Immunodeficiency: new trials by email Literature Review of Common Variable Immunodeficiency trials Research Report on Common Variable Immunodeficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies Alemtuzumab 0.3 mg, Cyclophosphamide, Busulfan - SCID, Omenn's Syndrome | Not applicable | Active not recruiting | Masonic Cancer Center, University of Minnesota | 57 | 2012-09-04 | 2026-06-17 |
Chediak-Higashi Syndrome (1) · Granulomatous Disease, Chronic (1) · Histiocytosis, Langerhans-Cell (1) · Hyper-IgM Immunodeficiency Syndrome (1) · Immunologic Deficiency Syndromes (1) · Lymphohistiocytosis, Hemophagocytic (1) · Lymphoproliferative Disorders (1) · Reticular dysgenesis (1) · Severe Combined Immunodeficiency (1) · Wiskott-Aldrich Syndrome (1)
Albinism (1) · Blood Coagulation Disorders (1) · Blood Coagulation Disorders, Inherited (1) · Blood Protein Disorders (1) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Cytopenia (1) · DNA Repair-Deficiency Disorders (1) · Disease Attributes (1) · Dysgammaglobulinemia (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1) · Hematologic Diseases (1)
Alemtuzumab (1) · Busulfan (1) · Cyclophosphamide (1) · Melphalan (1) · Mesna (1) · Sodium (1) · Stem Cell Transplantation (1) · fludarabine phosphate (1)
Masonic Cancer Center, University of Minnesota (1)
United States (1)